Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00197444
What this trial is testing

Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer

Who this might be right for
Esophageal CancerSquamous Cell Carcinoma
Hamamatsu University 33
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)UnknownNCT00008047
What this trial is testing

Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)UnknownNCT00682227
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 10
Testing effectiveness (Phase 2)UnknownNCT01795768
What this trial is testing

Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

Who this might be right for
Gastric CancerOesophageal CancerBreast Cancer+1 more
Royal Marsden NHS Foundation Trust 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Sun Yat-sen University 75
Large-scale testing (Phase 3)UnknownNCT01745107
What this trial is testing

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;

Who this might be right for
Esophageal NeoplasmEsophageal Cancer TNM Staging Primary Tumor (T) T2Esophageal Cancer TNM Staging Primary Tumor (T) T3+2 more
Chinese Academy of Medical Sciences 240
Testing effectiveness (Phase 2)Looking for participantsNCT06122493
What this trial is testing

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Ruijin Hospital 48
Not applicableActive Not RecruitingNCT07605663
What this trial is testing

An AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 890
Not applicableLooking for participantsNCT06476067
What this trial is testing

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerRecurrenceDNA Methylation
City of Hope Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT04212598
What this trial is testing

The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wuhan University 40
Testing effectiveness (Phase 2)UnknownNCT05791136
What this trial is testing

Immunotherapy After Radiotherapy in Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)UnknownNCT06186609
What this trial is testing

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Hospital of Nantong University 68
Testing effectiveness (Phase 2)Looking for participantsNCT07266480
What this trial is testing

Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.

Who this might be right for
Squamous Oesophageal Cancer
Hebei Medical University Fourth Hospital 142
Large-scale testing (Phase 3)Not Yet RecruitingNCT07788001
What this trial is testing

A Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus Conventional Lymph Node Dissection in Esophageal Cancer

Who this might be right for
Esophageal CancerSentinel Lymph NodeLymphadenectomy+2 more
Fujian Medical University Union Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05176002
What this trial is testing

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Who this might be right for
Esophageal NeoplasmImmunotherapyRadiotherapy
Fujian Medical University Union Hospital 25
Large-scale testing (Phase 3)Ended earlyNCT00190554
What this trial is testing

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsCarcinoma, Squamous Cell
Japan Clinical Oncology Group 330
Not applicableNot Yet RecruitingNCT07388095
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 22
Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Next Page